Long-term physiological T3 supplementation in hypertensive heart disease in rats
about
Safe Oral Triiodo-L-Thyronine Therapy Protects from Post-Infarct Cardiac Dysfunction and Arrhythmias without Cardiovascular Adverse EffectsTRIIODOTHYRONINE ATTENUATES PROSTATE CANCER PROGRESSION MEDIATED BY β-ADRENERGIC STIMULATIONCardioprotection and thyroid hormones.Modified Low-Dose Triiodo-L-thyronine Therapy Safely Improves Function Following Myocardial Ischemia-Reperfusion Injury.Comparison of therapeutic triiodothyronine versus metoprolol in treatment of myocardial infarction in rats.
P2860
Long-term physiological T3 supplementation in hypertensive heart disease in rats
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Long-term physiological T3 supplementation in hypertensive heart disease in rats
@ast
Long-term physiological T3 supplementation in hypertensive heart disease in rats
@en
type
label
Long-term physiological T3 supplementation in hypertensive heart disease in rats
@ast
Long-term physiological T3 supplementation in hypertensive heart disease in rats
@en
prefLabel
Long-term physiological T3 supplementation in hypertensive heart disease in rats
@ast
Long-term physiological T3 supplementation in hypertensive heart disease in rats
@en
P2093
P2860
P1476
Long-term physiological T3 supplementation in hypertensive heart disease in rats
@en
P2093
A Martin Gerdes
Adrienne Koder
Christine J Pol
Daria Colligiani
Nathan Y Weltman
Sarah Raza
Youhua Zhang
P2860
P304
P356
10.1152/AJPHEART.00431.2015
P577
2015-08-07T00:00:00Z